Is platinib included in medical insurance? The latest news on medical insurance in 2024

Platinib, developed and produced byBlueprint Medicines, is a receptor tyrosine kinase RET inhibitor mainly used to treat adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are positive for transfection rearrangement (RET) gene fusion. In addition, platinib is also indicated for the treatment of adults and pediatric patients 12 years and older with advanced or metastatic RET-mutated medullary thyroid carcinoma (MTC) who require systemic therapy. As a potent and highly selective drug, platinib effectively inhibits cell proliferation by inhibiting the phosphorylation of RET and its downstream molecules, bringing new treatment hope to cancer patients.

However, regarding the question of whether Platinib has been included in medical insurance,The latest news in 2024 is that the drug has not yet been included in the national medical insurance catalog, and patients still need to purchase it at their own expense. For many patients, this undoubtedly adds to the financial burden. However, it is gratifying that the medical insurance policy is constantly being adjusted and improved. Patients and their families can wait patiently for relevant information from the Medical Insurance Bureau, and look forward to Platinib being included in medical insurance in the future to reduce the financial pressure on patients.

While waiting for adjustments to medical insurance policies, patients with greater financial pressure may consider using generic drugs. The generic version of Platinib launched by Lucius Pharmaceuticals in Laos is 100mg*120 tablets, and a box sells for about 4,000 to 5,000 yuan. Although the prices of overseas drugs may change due to factors such as exchange rates and market supply and demand, generally speaking, the prices of generic drugs are more affordable than original drugs.

It is worth noting that the generic version of Platinib from Lucius Pharmaceuticals in Laos has been approved by the government. It is a regular drug approved by Laos and its quality is guaranteed. When patients choose to purchase drugs overseas, they can consult some reputable overseas medical institutions to ensure that the sources of drugs are reliable and safe and effective.

In short, although platinib is not currently included in medical insurance, patients and family members can pay attention to the latest developments in medical insurance policies and consider using generic drugs as a way to alleviate the financial burden. During medication, be sure to follow the doctor's instructions to ensure treatment effectiveness and safety.